Clinical Trial

A Study to Evaluate the Safety and Pharmacokinetics of UI087 Compared to Coadministration of UIC202506, UIC202507 and UIC202508 in Healthy Adult Volunteers Under Fasting Conditions

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study was an open-label, randomized, single-dose, 2-sequence, 2-period, crossover study to evaluate the safety and pharmacokinetics of UI087 compared to coadministration of UIC202506, UIC202507 and UIC202508 in healthy adult volunteers under fasting conditions
Trial Details
NCT Number NCT07548957
Lead Sponsor Korea United Pharm. Inc.
Conditions Diabetes Mellitus (Type 2)
Enrollment 44 participants
Start Date 2026-04
Primary Completion 2026-08 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-04-23